SEC 13F Intelligence

Commodore Capital LP / OPHTEUR

Commodore Capital LP’s Iveric Bio Inc Position

Does Commodore Capital LP own Iveric Bio Inc (OPHTEUR)? Not currently — the last reported position was 2.41M shares worth $23M in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$23M
Q2 2022
Shares
2.41M
% of Portfolio
+4.90%
Quarters Held
7
position exited

Position History OPHTEUR

Reported value by quarter
Q4 ’20: $9MQ4 ’20Q1 ’21: $11MQ1 ’21Q2 ’21: $11MQ2 ’21Q3 ’21: $45MQ3 ’21Q4 ’21: $54MQ4 ’21Q1 ’22: $37MQ1 ’22Q2 ’22: $23MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20222.41M$23M+4.90%
Q1 20222.21M$37M+8.33%
Q4 20213.22M$54M+12.46%
Q3 20212.75M$45M+11.78%
Q2 20211.75M$11M+3.80%
Q1 20211.73M$11M+4.21%
Q4 20201.27M$9M+4.79%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of OPHTEUR.